carfilzomib,elotuzumab,lenalidomide,dexamethasone
bms,abbvie
['dexamethasone', 'mmsm', 'lenalidomide', 'elotuzumab', 'carfilzomib', 'krd ', ' lena']
aa1/dsmm xvii study: carfilzomib, lenalidomide, and dexamethasone (krd) vs elotuzumab and krd elo-krd in ndmm: - rct, phase iii/ ndmm
- % high risk (16-17%) without 1q
- 6 cycles induction (4v3)/ consolidation 4 cycles (4v3)!! #asco23 #mmsm #myeloma #medtwitter #usmirc 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter